BioVie Inc.
BIVI
$0.8502
$0.01021.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.29% | 6.78% | 2.26% | -21.66% | -48.83% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.95% | -62.10% | -56.36% | -43.87% | -23.61% |
| Operating Income | 16.95% | 62.10% | 56.36% | 43.87% | 23.61% |
| Income Before Tax | 15.34% | 61.23% | 45.78% | 46.36% | 46.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.34% | 61.23% | 45.78% | 46.36% | 46.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.34% | 61.23% | 45.78% | 46.36% | 46.44% |
| EBIT | 16.95% | 62.10% | 56.36% | 43.87% | 23.61% |
| EBITDA | 17.06% | 62.43% | 56.66% | 44.05% | 23.72% |
| EPS Basic | 79.31% | 76.01% | 67.82% | 53.06% | 56.27% |
| Normalized Basic EPS | 79.44% | 77.75% | 67.82% | 57.71% | 56.27% |
| EPS Diluted | 79.10% | 76.03% | 66.93% | 53.49% | 56.27% |
| Normalized Diluted EPS | 79.44% | 77.75% | 67.82% | 57.71% | 56.27% |
| Average Basic Shares Outstanding | 311.76% | 74.22% | 68.49% | 26.82% | 22.46% |
| Average Diluted Shares Outstanding | 311.76% | 74.22% | 68.49% | 26.82% | 22.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |